@HepDART dr. Martins @Allergan summarizes ph3 trials planned in progress #obeticholicacid #cenicriviroc #aramchol #resmetirom #elafibranor #belapectin #galectin #hepdart

@EASLedu Prof. Ratziu: year 2 CENTAUR-2 RCT study of #cenicriviroc in NASH shows that it basically doesn’t reduce fibrosis meaningfully for most but may work better for people for advanced fibrosis #ilc2018

@easledu #cenicriviroc seems to reduce inflammation and fibrosis in animal models of alcoholic hepatitis. No data in humans. #ilc2017

@AASLDtweets Dr. Sanyal: 1y of #cenicriviroc vs placebo no better at reducing NAS score, less fibrosis in subsets #livermtg16

@ILCpress Dr. Puengel: #cenicriviroc ameliorates steatohepatitis in a not so physiologic animal model of MCD-deficient diet #ILC2016

404 Not Found

$TBRA to share ph1 data for CCR2/CCR5 antagonist #cenicriviroc in #NASH. CENTAUR ph2 study fully accrued. #liver15 http://news.sys-con.com/node/3484395